These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2690 related items for PubMed ID: 795538

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313).
    Németh L, Institóris L, Somfai S, Gál F, Pályi I, Sugár J, Csuka O, Szentirmay Z, Kellner B.
    Cancer Chemother Rep; 1972 Oct; 56(5):593-602. PubMed ID: 4652589
    [No Abstract] [Full Text] [Related]

  • 43. Gas-chromatographic analysis for 1,2:5,6-dianhydrogalactitol, an anti-neoplastic agent, in plasma.
    Kimura T, Sternson LA, Higuchi T.
    Clin Chem; 1976 Oct; 22(10):1639-43. PubMed ID: 975510
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Cell killing, kinetics, and recovery responses induced by 1,2:5,6-dianhydrogalactitol in dividing and nondividiing cells in vitro.
    Barranco SC, Flournoy DR.
    J Natl Cancer Inst; 1977 Mar; 58(3):657-63. PubMed ID: 839561
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group study.
    Stehman FB, Blessing JA, Homesley HD, Currie JL, Yordan EL.
    Invest New Drugs; 1984 Mar; 2(3):331-3. PubMed ID: 6511240
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Phase I and II studies with hexitol derivatives, formyl-leurosine and ftorafur.
    Eckhardt S.
    Antibiot Chemother (1971); 1978 Mar; 23():50-7. PubMed ID: 348087
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Clinical observation of 15 cases of chronic myelogenous leukemia treated with 1,2,5,6-dianhydrodulcitol].
    Huang ZG.
    Zhonghua Nei Ke Za Zhi; 1982 Jun; 21(6):356-8. PubMed ID: 6957285
    [No Abstract] [Full Text] [Related]

  • 56. Derivatives of 2,3-anhydro-DL-threitol, 2,3-anhydroerythritol, 2,3:4,5-dianhydrogalactitol, and 2,3:4,5-dianhydroallitol.
    Schneider G, Horváth T, Sohár P.
    Carbohydr Res; 1977 Jun; 56(1):43-52. PubMed ID: 880588
    [Abstract] [Full Text] [Related]

  • 57. The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcoma.
    Fuzy M, Lelieveld P, Van Putten LM.
    Eur J Cancer (1965); 1975 Mar; 11(3):169-73. PubMed ID: 165939
    [No Abstract] [Full Text] [Related]

  • 58. High-performance liquid chromatographic analysis of dianhydrogalactitol in plasma by derivatization with sodium diethyldithiocarbamate.
    Munger D, Sternson LA, Repta AJ, Higuchi T.
    J Chromatogr; 1977 Jul 01; 143(4):375-82. PubMed ID: 195971
    [Abstract] [Full Text] [Related]

  • 59. Initial clinical studies of piritrexim.
    Laszlo J, Brenckman WD, Morgan E, Clendeninn NJ, Williams T, Currie V, Young C.
    NCI Monogr; 1987 Jul 01; (5):121-5. PubMed ID: 3323908
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 135.